Skip to Content

Epaned Approval History

FDA Approved: Yes (First approved August 13, 2013)
Brand name: Epaned
Generic name: enalapril maleate
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals
Treatment for: High Blood Pressure, Heart Failure, Left Ventricular Dysfunction

Epaned (enalapril maleate) is an angiotensin-converting enzyme inhibitor indicated for the treatment of hypertension in adults and children older than one month, symptomatic heart failure, and asymptomatic left ventricular dysfunction.

Development History and FDA Approval Process for Epaned

DateArticle
Jan 10, 2017Approval Epaned (enalapril maleate) Oral Solution is Now Available
Sep  8, 2014Approval FDA Approves Two New Indications for Epaned, the First and Only Enalapril Powder for Oral Solution
Aug 14, 2013Approval FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide